THE MCMANUS GROUP for ZIMMER BIOMET
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers. Medicare Beneficiary Co-Pay Fairness Act of 2025 (H.R. 3006/S. 1776)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAWREN D GEER | — |
| JOHN MCMANUS | — |
| ALEX WHALEN | — |
Health Issues HCR
Issues related to Artificial Intelligences approval in Medical Devices.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAWREN D GEER | — |
| JOHN MCMANUS | — |
| ALEX WHALEN | — |
Taxation/Internal Revenue Code TAX
Issues related to corporate tax policy, including the corporate tax rate, R&D expensing, FDII extension, and implementation of the OECD global minimum tax (Pillar II).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.